These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


114 related items for PubMed ID: 9689457

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel potential antidementia drug, restores the regional cerebral blood flow response abolished by scopolamine but not by HA-966: a positron emission tomography study with unanesthetized rhesus monkeys.
    Tsukada H, Yamazaki S, Noda A, Inoue T, Matsuoka N, Kakiuchi T, Nishiyama S, Nishimura S.
    Brain Res; 1999 Jun 19; 832(1-2):118-23. PubMed ID: 10375657
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Scopolamine abolishes cerebral blood flow response to somatosensory stimulation in anesthetized cats: PET study.
    Ogawa M, Magata Y, Ouchi Y, Fukuyama H, Yamauchi H, Kimura J, Yonekura Y, Konishi J.
    Brain Res; 1994 Jul 11; 650(2):249-52. PubMed ID: 7953689
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cerebral blood flow responses to somatosensory stimulation are unaffected by scopolamine in unanesthetized rat.
    Nakao Y, Gotoh J, Kuang TY, Cohen DM, Pettigrew KD, Sokoloff L.
    J Pharmacol Exp Ther; 1999 Aug 11; 290(2):929-34. PubMed ID: 10411611
    [Abstract] [Full Text] [Related]

  • 14. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats.
    Löscher W, Wlaź P, Rundfeldt C, Baran H, Hönack D.
    Br J Pharmacol; 1994 May 11; 112(1):97-106. PubMed ID: 8032669
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Physostigmine reversal of scopolamine-induced hypofrontality.
    Prohovnik I, Arnold SE, Smith G, Lucas LR.
    J Cereb Blood Flow Metab; 1997 Feb 11; 17(2):220-8. PubMed ID: 9040502
    [Abstract] [Full Text] [Related]

  • 17. Neurochemical stimulation of the rat substantia innominata increases cerebral blood flow (but not glucose use) through the parallel activation of cholinergic and non-cholinergic pathways.
    Barbelivien A, Bertrand N, Besret L, Beley A, MacKenzie ET, Dauphin F.
    Brain Res; 1999 Sep 04; 840(1-2):115-24. PubMed ID: 10517959
    [Abstract] [Full Text] [Related]

  • 18. Cholinergic enhancement eliminates modulation of neural activity by task difficulty in the prefrontal cortex during working memory.
    Furey ML, Ricciardi E, Schapiro MB, Rapoport SI, Pietrini P.
    J Cogn Neurosci; 2008 Jul 04; 20(7):1342-53. PubMed ID: 18284346
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Metabolic effects of scopolamine and physostigmine in human brain measured by positron emission tomography.
    Blin J, Piercey MF, Giuffra ME, Mouradian MM, Chase TN.
    J Neurol Sci; 1994 May 04; 123(1-2):44-51. PubMed ID: 8064320
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.